L
L Anderson
Publications - 2
Citations - 1652
L Anderson is an academic researcher. The author has contributed to research in topics: Adverse effect & Pravastatin. The author has an hindex of 2, co-authored 2 publications receiving 1645 citations.
Papers
More filters
Journal ArticleDOI
West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials
J. Shepherd,Stuart M. Cobbe,AR Lorimer,James H. McKillop,Jane B. Ford,Christopher J. Packard,Peter W. Macfarlane,Chris Isles,MF Oliver,A. F. Lever,BW Brown,Jgg Ledingham,SJ Pocock,BM Rifkind,B. D. Vallance,David Ballantyne,L Anderson,D Duncan,Sharon Kean,A Lawrence,John J. McGrath,K Montgomery,John Norrie,M Percy,E Pomphrey,Andrew J. O. Whitehouse,Peter Cameron,P Parker,F Porteous,L Fletcher,C Kilday,D Shoat,S Latif,James L. Kennedy,M A Bell,R Birrell,M Mellies,J Meyer,W Campbell +38 more
Journal Article
Compliance and adverse event withdrawal: their impact on the west of Scotland Coronary Prevention Study
J. Shepherd,Stuart M. Cobbe,AR Lorimer,James H. McKillop,Jane B. Ford,Christopher J. Packard,Peter W. Macfarlane,Chris Isles,MF Oliver,A. F. Lever,BW Brown,Jgg Ledingham,SJ Pocock,BM Rifkind,B D Vallance,David Ballantyne,L Anderson,D Duncan,Sharon Kean,A Lawrence,John J. McGrath,K Montgomery,John Norrie,M Percy,E Pomphrey,Andrew J. O. Whitehouse,Peter Cameron,P Parker,F Porteous,L Fletcher,C Kilday,D Shoat,S Latif,James L. Kennedy,M A Bell,R Birrell,M Mellies,J Mayers,W Campbell +38 more
TL;DR: The analysis of the effect of pravastatin in the subgroup of high compliers to randomized medication demonstrated a substantial increase in the estimated risk reductions in comparison with that achieved in the intention-to-treat analysis.